PharmaSpace SRL
2.4 FTEThe score of PharmaSpace shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +43 % Total assets -12 % Headcount (avg FTE) +20 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PharmaSpace's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 46,633 € | ||||
| Equity | 150,137 € | ||||
| Cash | 52,089 € | ||||
| EBITDA | 116,147 € | ||||
| Total assets | 495,059 € |
Filed annual accounts
- Year ended 30 Jun 2026filed on 29 Oct 2026
- Year ended 30 Jun 2025filed on 17 Nov 2025
- Year ended 30 Jun 2024filed on 01 Oct 2024
- Year ended 30 Jun 2023filed on 02 Oct 2023
- Year ended 30 Jun 2022filed on 15 Nov 2022
PharmaSpace's financial analysis
- Solvency30.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PharmaSpace
PharmaSpace's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0676.525.015
- VAT number
- BE0676525015
- Peppol
- Registered · 0208:0676525015 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Jun 2017
- Registered office
- 9051 Ghent
- Size
- Micro · 2.4 FTE
- Latest accounts
- 2026 · filed on 29 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
PharmaSpace (SRL) has been based in Ghent since 2017, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 46,633 € and equity of 150,137 €; its revenue is not published. With 2.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 30.3%, below the median of its sector (44.2%).
Companies similar to PharmaSpace
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie du progrès Retail sale of pharmaceutical products Charleroi · balance sheet 553,649 €
- Apotheek Geusens Retail sale of pharmaceutical products Pelt · balance sheet 404,835 €
- Verstraete Jeroen Apotheek Retail sale of pharmaceutical products Harelbeke · balance sheet 560,565 €
- Adriaens-Louis Retail sale of pharmaceutical products Mons · balance sheet 402,839 €
- Apoteek Mortier Retail sale of pharmaceutical products Oudenaarde · balance sheet 589,824 €
- Approver Retail sale of pharmaceutical products Lier · balance sheet 704,844 €
- Farma Booischot Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 558,918 €
- Pharmenform Retail sale of pharmaceutical products Koekelberg · balance sheet 567,837 €
Frequently asked questions about PharmaSpace
What is the revenue of PharmaSpace?
PharmaSpace files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of PharmaSpace?
In Belgium, the VAT number is the company number prefixed with BE: BE0676525015 for PharmaSpace, if the company is VAT-registered. Its company number (CBE) is 0676.525.015.
Where is the registered office of PharmaSpace?
According to the CBE register, the registered office of PharmaSpace is in 9051 Ghent.
What is the equity of PharmaSpace?
At the close of the 2026 financial year, the equity of PharmaSpace amounts to 150,137 €, a solvency of 30.3% of total assets.
How many people work at PharmaSpace?
2.4 full-time equivalents on average according to the 2026 social balance sheet.
Who manages PharmaSpace?
The register lists 3 active mandates at PharmaSpace. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PharmaSpace
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →